🇺🇸 FDA
Pipeline program

MIYAIRI 588

CMUH111-REC3-178

Approved small_molecule completed

Quick answer

MIYAIRI 588 for Depression Mild is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Depression Mild
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials